Statistics
Publications
5
Citations
170
H-Index
5
Active since
2022
Heloise Cheruvalath is an author at Medical College of Wisconsin specializing in relapsed multiple myeloma, cancer immunotherapy, and relapsed disease therapy.
Publications per year
2022–2025
5
5
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Meera Mohan, Jorge Monge, Nishi Shah et al. · Blood Cancer Journal · 2024 · 97 citations · Full text
Medicine, Oncology, Pharmacotherapy +16
Meera Mohan, Anikó Szabó, Heloise Cheruvalath et al. · Blood Cancer Journal · 2025 · 30 citations · Full text
Heloise Cheruvalath, Jennifer K. Homa, Maharaj Singh et al. · Journal of patient-centered research and reviews · 2022 · 11 citations · Full text
Teclistamab in Relapsed Refractory Multiple Myeloma: Multi-Institutional Real-World Study
Meera Mohan, Nishi Shah, Danny Luan et al. · Blood · 2023 · 10 citations
Medicine, Oncology, Pharmacotherapy +16
1–5 of 5